U of M Medical School researchers combine ultrasound with engineered glass particles to boost the effectiveness of immunotherapy to combat brain cancer.

Badrinath Konety, MD, discusses the latest treatments available for bladder cancer patients and research in the field.

The Minnesota Symposium is a biennial meeting on a selected topic in the study of developmental psychology.

New research from the University of Minnesota Medical School found a little stress can make the circadian clock run better and faster.

Michael Kyba, PhD, Darko Bosnakovski, DVM, PhD, and their team discovered a way to deactivate DUX4 and take away the toxic effects in cells, as well as in a mouse model for FSHD.

New research has shown that survival outcomes for pediatric cancer patients after an organ transplant were very promising and appeared similar to general outcomes. This study demonstrated it is a viable option for physicians and insurance companies to consider when making a decision.

On July 31, Cardio Palooza broke records and brought in more than 200 scholars from throughout the University, including 84 poster presenters and 36 faculty judges.

The National Academy of Medicine has identified a CMV vaccine as being the highest public health priority for any new vaccine.

New research from the University of Minnesota Medical School has discovered critical mutations in molecules implicated in obesity, which may help inform the development of new anti-obesity therapies.

The University of Minnesota Medical School is at the forefront of developing a cell-based therapy for Duchenne muscular dystrophy (DMD).